Adam K. Simpson

This profile gathers the share dealings of Adam K. Simpson in Icosavax, Inc., where the filings describe the role as chief executive. We count 38 filings; the first trade dates from 30 July 2021 and the latest from 19 February 2024.

No open-market purchase appears, only 11 sales worth €3.4M. Outside the open market, there are 2 share grants and 16 option exercises. So far in 2024, the count stands at no purchases and 2 sales.

The latest filing, published on 20 February 2024, reports a transaction in Icosavax, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.